3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
4
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other solid neoplasm
54
Other hematologic neoplasm
29
Breast
27
Gastrointestinal
23
Thoracic
22
Lymphoid
21
Genitourinary
14
Gynecologic
12
Myeloid
11
CNS
5
Plasma cell
4
Head & Neck
4
NET
3
Endocrine
3
Tumor-Agnostic
2
Sarcoma
2
Dermatologic
2
Classical hematology
2
Other
1
Conditions
Stomatitis
1
Mucositis
1
Mouth Neoplasms
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Interventions
Tirzepatide
5
Educational Status
4
naldemedine
3
Methods
3
Interviews as Topic
3
Early Intervention, Educational
3
semaglutide
2
Tablets
2
Standard of Care
2
Specimen Handling
2
Radiotherapy
2
Paclitaxel
2
Observation
2
Mouthwashes
2
Metformin
2
Exercise
2
Counseling
2
Cisplatin
2
Carboplatin
2
trametinib
1
tempol
1
sotorasib
1
selpercatinib
1
polyethylene glycol 3350
1
pembrolizumab
1
osimertinib
1
naloxegol
1
mirabegron
1
maltodextrin
1
ma zi ren wan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Injections
×
Other
×
Clear all
NCT05966194
2024-11-15
KEVLARx
EpicentRx, Inc.
Phase 2
Recruiting
216 enrolled